Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Cowen & Co. analyst Jeffrey Osborne upgrades Shoals Technologies Gr (NASDAQ:SHLS) from Market Perform to Outperform and raises the price target from $29 to $37.5.